Transcatheter Aortic Valve Implantation: Early Experience in Korea

다국어 초록 (Multilingual Abstract)

Background and Objectives: Transcatheter aortic valve implantation (TAVI) was recently introduced in Korea. The present report describes the experience of early TAVI cases.
Subjects and Methods: Between March, 2010 and October, 2011, 48 patients with severe symptomatic aortic stenosis (AS) were screened at the Asan Medical Center to determine their suitability for surgical intervention. Of these, 23 were considered unsuitable and underwent TAVI. Procedural success rates, procedure-related complications, and clinical outcomes were evaluated in the TAVI patients.
Results: Transfemoral (n=20) or transapical (n=3) TAVI was performed. The mean age of patients was 75.9±5.4 years and 57% were fe-males. The mean logistic European System for Cardiac Operative Risk Evaluation was 25.6±5.1%. Implantation was successful in 22 pa-tients (19 transfemoral, three transapical). After successful implantation, the mean aortic valve area increased from 0.68±0.14 cm 2 to 1.45±0.33 cm 2 . There were no procedure-related complications or mortality. The patients showed no paravalvular aortic regurgitation with ≥ moderate degree and remained stable without progression during follow-up. During follow-up (interquartile range, 1.1-12.9), all pa-tients were alive without any occurrence of valve failure.
Conclusion: TAVI procedure is feasible in patients with inoperative symptomatic AS leading to hemodynamic and clinical improvement.
With accumulation of experience, proper patient selection and development of device technologies, TAVI should decrease adverse events and expand the indications in the near future.

참고문헌 (Reference)

1 Smith CR, "Transcatheter versus surgical aortic-valve replacement in high-risk patients" 364 : 2187-2198, 2011

2 Leon MB, "Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery" 363 : 1597-1607, 2010

3 Serruys PW, "Transcatheter aortic valve implantation: tips and tricks to avoid failure. 1st ed" Informa Healthcare 645-657, 2009

4 Buellesfeld L, "Transcatheter aortic valve implantation: predictors of procedural success: the Siegburg- Bern experience" 31 : 984-991, 2010

5 Gurvitch R, "Transcatheter aortic valve implantation: lessons from the learning curve of the first 270 high-risk patients" 78 : 977-984, 2011

6 Lichtenstein SV, "Transapical transcatheter aortic valve implantation in humans: initial clinical experience" 114 : 591-596, 2006

7 Otto CM, "Three-year outcome after balloon aortic valvuloplasty: insights into prognosis of valvular aortic stenosis" 89 : 642-650, 1994

8 Schwarz F, "The effect of aortic valve replacement on survival" 66 : 1105-1110, 1982

9 Vassiliades TA Jr, "The clinical development of percutaneous heart valve technology: a position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society of Cardiovascular Angiography and Intervention (SCAI)" 65 : 73-79, 2005

10 Kurra V, "Pre-procedural imaging of aortic root orientation and dimensions: comparison between X-ray angiographic planar imaging and 3-dimensional multidetector row computed tomography" 3 : 105-113, 2010

11 Cribier A, "Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description" 106 : 3006-3008, 2002

12 Webb JG, "Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis" 116 : 755-763, 2007

13 Webb JG, "Percutaneous aortic valve implantation retrograde from the femoral artery" 113 : 842-850, 2006

14 Kvidal P, "Observed and relative survival after aortic valve replacement" 35 : 747-756, 2000

15 Messika-Zeitoun D, "Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation" 55 : 186-194, 2010

16 Bach DS, "Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: the potential role of subjectively overestimated operative risk" 2 : 533-539, 2009

17 Ng AC, "Comparison of aortic root dimensions and geometries before and after transcatheter aortic valve implantation by 2- and 3-dimensional transesophageal echocardiography and multislice computed tomography" 3 : 94-102, 2010

18 Nkomo VT, "Burden of valvular heart diseases: a population-based study" 368 : 1005-1011, 2006

19 Bonow RO, "ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons" 114 : e84-e231, 2006

20 Iung B, "A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease" 24 : 1231-1243, 2003